We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

162 hedge funds and large institutions have $867M invested in Ariad Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 64 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% more call options, than puts

Call options by funds: $7.3M | Put options by funds: $3.77M

7% more capital invested

Capital invested by funds: $812M → $867M (+$54.8M)

6% less funds holding

Funds holding: 172 → 162 (-10)

24% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 29

30% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 64

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
162
Holders Change
-10
Holders Change %
-5.81%
% of All Funds
4.32%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
22
Increased
45
Reduced
64
Closed
29
Calls
$7.3M
Puts
$3.77M
Net Calls
+$3.53M
Net Calls Change
-$522K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$31.3M
2
PI
Putnam Investments
Massachusetts
+$14.9M
3
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$9.03M
4
TA
Tamarack Advisers
California
+$8.97M
5
JIM
Jupiter Investment Management
United Kingdom
+$6.86M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.8M
2
State Street
State Street
Massachusetts
-$6.68M
3
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$6.11M
4
BNP Paribas Asset Management
BNP Paribas Asset Management
France
-$5.94M
5
UBS Group
UBS Group
Switzerland
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$1.82M -$2.02M -360,128 -56%
Swiss National Bank
52
Swiss National Bank
Switzerland
$1.81M +$332K +59,200 +25%
CS
53
Credit Suisse
Switzerland
$1.73M +$674K +120,302 +80%
Morgan Stanley
54
Morgan Stanley
New York
$1.7M +$158K +28,222 +12%
PIM
55
Platinum Investment Management
Australia
$1.6M +$773K +138,000 +123%
1CM
56
1492 Capital Management
Wisconsin
$1.29M – – –
FM
57
Family Management
New York
$1.14M +$82.7K +14,750 +9%
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$1.11M -$1.71K -305 -0.2%
BG
59
BlackRock Group
United Kingdom
$1.1M +$107K +19,123 +13%
CS
60
Candriam SCA
Luxembourg
$1.08M +$953K +170,000 New
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$1.05M -$165K -29,480 -15%
ProShare Advisors
62
ProShare Advisors
Maryland
$1.03M -$86K -15,346 -9%
BA
63
BlackRock Advisors
Delaware
$950K +$33.5K +5,981 +4%
MIG
64
Mariner Investment Group
New York
$912K – – –
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$871K – – –
UBS AM
66
UBS AM
Illinois
$836K -$78.3K -13,978 -10%
Citigroup
67
Citigroup
New York
$818K +$535K +95,506 +295%
SIM
68
Spark Investment Management
New York
$809K +$205K +36,600 +41%
UBS Group
69
UBS Group
Switzerland
$803K -$2.12M -378,818 -75%
EEG
70
E.E. Geduld
$767K -$364K -65,000 -35%
MLICM
71
Metropolitan Life Insurance Company (MetLife)
New York
$766K – – –
Bank of America
72
Bank of America
North Carolina
$749K -$140K -25,004 -18%
Wells Fargo
73
Wells Fargo
California
$731K +$122K +21,688 +23%
Citadel Advisors
74
Citadel Advisors
Florida
$716K +$568K +101,335 +945%
NFA
75
Nationwide Fund Advisors
Ohio
$706K -$18K -3,209 -3%
1 2
3
4 5

ARIA Hedge Fund Activity: Q1 2016 in Review

162 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2016, worth a combined $867M — up 6.8% from $812M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ARIA and 22 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 45 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $31.3M. The largest seller was Fidelity Investments, cutting an estimated $15.8M.

  • 162 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2016, down from 172 in Q4 2015.
  • Funds reported $867M of Ariad Pharmaceuticals Inc stock for Q1 2016, up 6.8% quarter-over-quarter.
  • 22 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2016 and 29 closed out, a net change of -7 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2016 was Consonance Capital Management, an estimated $31.3M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2016 was Fidelity Investments, an estimated $15.8M sold.

Based on aggregated 13F filings for Q1 2016.